PTN Palatin Technologies, Inc.
$4.77▼ -1.04%
Healthcare
Other
Volume 33.3K
Avg Volume (10D) 47.5K
Key Metrics & Fundamentals
Market Cap
$8.50M
P/E Ratio
94.1
Div Yield
0.00%
52W Range
4.58 - 31.00
% vs 50 MA
-49.60%
% vs 200 MA
-66.44%
RSI-14
19.5
MACD Histogram
-0.2400
Beta (1Y vs SPY)
0.02
Free Cash Flow
-$2.69M
Gross Rev
$300,770
Gross Profit
$300,770
EBITDA
-$4.40M
COGS
–
Operating Exp
$4.72M
Operating Income
-$4.42M
EBIT
-$4.42M
Pretax Income
-$4.36M
Net Income
-$4.36M
Price & Volume History
Loading chart…
Recent News
Palatin Technologies, Inc. Q4 2026 Earnings Call Summary
Moby · Sep 29, 2026 8:30 AM ET
Palatin Reports Fiscal Year 2026 Financial Results and Provides Business Update
PR Newswire · Sep 28, 2026 7:30 AM ET
StreetWatch: A $2.9 Billion Takeover Put a Spotlight on Relentless Hunger. Palatin Technologies Is Developing the Next Generation of the Drug That Seeks to Treat It
TMX Newsfile · Aug 6, 2026 9:40 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See PTN's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.